Rxo (RXO) Income from Continuing Operations (2021 - 2026)

Rxo (RXO) has reported Income from Continuing Operations for 6 consecutive years, with -$9.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Income from Continuing Operations changed 0.0% year-over-year to -$9.0 million; the trailing twelve-month figure through Jun 2026 stood at -$105.0 million (up 65.91% YoY), and the FY2025 full-year result was -$100.0 million, up 65.52% from the prior year.
• Income from Continuing Operations grew to -$9.0 million in Q2 2026 per RXO's latest filing, from -$36.0 million in the prior quarter.
• Across five years, Income from Continuing Operations topped out at $44.0 million in Q2 2022 and bottomed at -$243.0 million in Q3 2024.
• Historically, Income from Continuing Operations has averaged -$19.9 million across 5 years, with a median of -$9.0 million in 2025.
• The sharpest annual moves came in 2023 and 2024: Income from Continuing Operations jumped 150.0% in 2023, then sank 24200.0% in 2024.
• Over 5 years, Income from Continuing Operations stood at -$4.0 million in 2022, then surged by 150.0% to $2.0 million in 2023, then tumbled by 1350.0% to -$25.0 million in 2024, then sank by 84.0% to -$46.0 million in 2025, then soared by 80.43% to -$9.0 million in 2026.
• According to Business Quant data, Income from Continuing Operations over the past three periods registered -$9.0 million, -$36.0 million, and -$46.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.